1. Home
  2. ZVIA vs IPSC Comparison

ZVIA vs IPSC Comparison

Compare ZVIA & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zevia PBC

ZVIA

Zevia PBC

HOLD

Current Price

$1.91

Market Cap

193.4M

ML Signal

HOLD

Logo Century Therapeutics Inc.

IPSC

Century Therapeutics Inc.

HOLD

Current Price

$2.29

Market Cap

189.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZVIA
IPSC
Founded
2007
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Medicinal Chemicals and Botanical Products
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
193.4M
189.7M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
ZVIA
IPSC
Price
$1.91
$2.29
Analyst Decision
Buy
Strong Buy
Analyst Count
4
5
Target Price
$5.18
$3.50
AVG Volume (30 Days)
1.4M
2.9M
Earning Date
02-25-2026
03-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$162,849,000.00
$113,337,000.00
Revenue This Year
$7.60
$1,590.09
Revenue Next Year
$6.70
N/A
P/E Ratio
N/A
N/A
Revenue Growth
6.17
4122.69
52 Week Low
$1.66
$0.34
52 Week High
$4.51
$2.71

Technical Indicators

Market Signals
Indicator
ZVIA
IPSC
Relative Strength Index (RSI) 41.46 65.08
Support Level $1.81 $2.08
Resistance Level $2.12 $2.71
Average True Range (ATR) 0.12 0.33
MACD 0.04 0.03
Stochastic Oscillator 54.84 65.95

Price Performance

Historical Comparison
ZVIA
IPSC

About ZVIA Zevia PBC

Zevia PBC is a beverage company disrupting the liquid refreshment beverage industry through refreshing, zero-calorie, zero-sugar, naturally sweetened beverages that are all Non-GMO Project Verified. It offers a platform of products that include a variety of flavors across Soda, Energy Drinks, Organic Tea, Mixers, Kidz drinks, and Sparkling Water. Its products are distributed across the U.S. and Canada through a network of retailers in the food, drug, mass, natural, and e-commerce channels. The company derives a majority of its revenue from the United States.

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.

Share on Social Networks: